CM383 / Keymed Biosciences - LARVOL DELTA

Study of CM383 in Healthy Subjects (clinicaltrials.gov) - P1 | N=30 | Recruiting | Sponsor: Keymed Biosciences Co.Ltd | Not yet recruiting ➔ Recruiting

Enrollment open

Study of CM383 in Healthy Subjects (clinicaltrials.gov) - P1 | N=30 | Not yet recruiting | Sponsor: Keymed Biosciences Co.Ltd

New P1 trial

A First-in-Human, Single Dose-Escalation Study of CM383, a Novel Anti- Amyloid Beta antibody, in healthy volunteers (CTAD 2025) - No abstract available

Clinical • First-in-human • P1 data

A Study of CM383 in Patients With Alzheimer's Disease Related Mild Cognitive Impairment and Mild Alzheimer's Disease (clinicaltrials.gov) - P1 | N=48 | Recruiting | Sponsor: Keymed Biosciences Co.Ltd | Not yet recruiting ➔ Recruiting

Enrollment open • Alzheimer's Disease • CNS Disorders • Cognitive Disorders

Single Dose Escalation Study of CM383 in Healthy Volunteers (clinicaltrials.gov) - P1 | N=44 | Recruiting | Sponsor: Keymed Biosciences Co.Ltd | Not yet recruiting ➔ Recruiting

Enrollment open • Alzheimer's Disease • CNS Disorders

A Study of CM383 in Patients With Alzheimer's Disease Related Mild Cognitive Impairment and Mild Alzheimer's Disease (clinicaltrials.gov) - P1 | N=48 | Not yet recruiting | Sponsor: Keymed Biosciences Co.Ltd

New P1 trial • Alzheimer's Disease • CNS Disorders • Cognitive Disorders

Single Dose Escalation Study of CM383 in Healthy Volunteers (clinicaltrials.gov) - P1 | N=44 | Not yet recruiting | Sponsor: Keymed Biosciences Co.Ltd

New P1 trial • Alzheimer's Disease • CNS Disorders